Breast augmentation surgery is the most common cosmetic surgery in the United States, and seroma is a known complication of breast augmentation. However, late seroma is a rare event and is most associated with textured implants. A 29-year-old woman with a remote history of breast implantation presented to the plastic surgery clinic for evaluation of a swollen breast, which began 24 h postpartum. Magnetic resonance imaging revealed peri-implant fluid maintained within the fibrous capsule. The patient was managed conservatively and the swelling self-resolved without recurrence. The authors report the first known case of a late seroma associated with pregnancy, occurring nine years postoperatively.
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evidence of erythema on examination. An ultrasound detected a 1.4 cm septated fluid collection superficial to the implant without evidence of a fibroglandular breast abscess. The radiologist concluded it was an acute rupture of the left breast retropectoral silicon prosthesis, with an extracapsular reactive hematoma or seroma. The emergency physicians diagnosed a likely ruptured left breast implant, referred her to a plastic surgeon and prescribed a course of clindamycin.
She was seen by a plastic surgeon three days later; the patient was noted to have painful left breast swelling without erythema. The antibiotics did not improve her condition. Magnetic resonance imaging (MRI) revealed no evidence of implant rupture and a moderate amount of peri-implant fluid maintained within the fibrous capsule ( Figure 1 ). The surgeon concluded the patient experienced a late seroma secondary to the double capsule phenomenon associated with implants. The patient was managed conservatively through regular follow-up, and the seroma was never aspirated.
The patient returned to clinic for follow-up two months later with significant resolution of symptoms, and there was no subsequent recurrence or complication.
DISCUSSION
Breast augmentation is an increasingly common procedure, and known complications include capsular contracture, infection, galactocele, hematoma and seroma (8) . Late seromas, arbitrarily defined as occurring ≥1 year postoperatively, are very rare (7) . Late seromas among primary augmentations occur ≤1% of the time (3) (4) (5) . Evidence shows that textured implants are more likely to be associated with late seroma formation (6) , with one study reporting that 96% of late seromas occurred with textured devices in place (7) .
A 'seroma' can be further described by the contents of the fluid (9). The fluid is known as a serous effusion if the fluid has <2.0 g/dL of protein. If there is a high protein content (>2.9 g/dL), it is known as an exudate. The fluid is known as a hematoma if there is a large amount of red blood cells present. The effusion is inflammatory if it comprises predominantly white blood cells. Finally, the fluid is malignant if cancer cells exist (9) . Non-Hodgkin T cell lymphoma of the breast, currently known as anaplastic large T cell lymphoma, can present as a late seroma following breast augmentation (9) . The incidence of anaplastic large T cell lymphoma is extremely low and is estimated to be 1 per 1 million women per year (10) .
Suspected causes of late seromas have included clinical infection, subclinical infection (including biofilm), malignancy (including anaplastic large T cell lymphoma), capsule tear, microtrauma and idiopathic (7) . Mechanical factors, such as shearing of cutaneous surfaces on the underlying musculature, have also been implicated in the formation of seromas (11) .
Physiological changes of the breast during pregnancy likely had an impact on the formation of the late seroma. Interestingly, the patient had previously delivered two other children without any seroma formation.
In our literature review, there were no other documented late seromas occurring in pregnancy. In 2008, Akali and McArthur (12) reported a patient who experienced a late seroma in the postpartum period. This 25 year-old patient experienced a late seroma seven years after submammary breast augmentation with textured round silicon implants. Two weeks postpartum, the woman experienced mastitis. Subsequently, a seroma developed two weeks postmastitis, which was treated with fluid aspiration and conservative treatment.
In addition, Roth et al (8) presented the first case report to document a seroma during pregnancy. This 29-year-old woman had microtexturized silicone breast implants, and she developed a seroma at three weeks' gestation. However, the seroma occurred only three months after surgical implantation. This seroma underwent aspiration and no malignant or abnormal cells were detected. The patient experienced recurrence and, ultimately, underwent surgical exploration, excision and capsulectomy.
Due to the lack of trial-based evaluation for the management of late seromas, Bengtson et al (9) presented a best-practice consensus algorithm for the management of late seromas. Due to the nature of a partially commercially funded, consensus-based set of recommendations, dissenters (13) and supporters (14) will continue to debate the merits of these recommendations.
The consensus paper prioritized ruling out infection as a first step in management. A complete blood count, culture and cell count of aspirated periprosthetic fluid, and antibiotics were recommended as the first step in management (9) .
If the swelling persists or recurs, Bengtson et al (9) recommend ultrasound-guided or simple needle aspiration to obtain periprosthetic fluid drainage for culture, cell count and/or cytology. Mammography is not recommended because it may cause pain or injury and is less clinically useful than ultrasound. Magnetic resonance imaging may be useful in detecting implant rupture and providing a diagnosis of a fluid collection versus generalized breast tissue swelling (9) . In addition, the consensus recommended against nontreatment and repeating ultrasound-guided aspiration of fluid that recurs (9) .
In addition to Bengtson et al (9) , a 2011 article by Spear et al (7) examined the management practices of late seroma in three separate plastic surgeons. Of 28 late seroma cases, 96% of patients were successfully treated using a variety of modalities. Methods ranged from conservative management with antibiotics alone (10.7% of patients) to complete capsulectomy, seroma drainage and implant replacement (53.6% of patients). None of the patients had positive cytology studies for malignancy or infection; thus, no clear etiology could be identified in the vast majority of patients (7) .
In conclusion, late seroma among primary augmentations occurs ≤1% the time (3) (4) (5) . Late seroma has been reported with implants (6,7), but has never been reported in pregnancy. The only other known documented case of a seroma associated with pregnancy occurred three months postoperatively (8) . We present the first case of a late seroma associated with pregnancy, occurring nine years after implantation.
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